Evolent Health
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $479,533 | $444,328 | $483,649 | $646,542 |
Gross Profit | 99,774 | 100,385 | 102,471 | 75,711 |
EBITDA | 14,532 | 12,771 | -28,705 | 13,287 |
EBIT | -3,483 | -10,370 | -52,763 | -17,203 |
Net Income | -20,864 | -19,897 | -64,618 | -22,802 |
Net Change In Cash | 479,533 | 444,328 | 483,649 | 646,542 |
Free Cash Flow | 6,850 | -39,104 | -4,030 | -32,381 |
Cash | 116,650 | 150,995 | 246,547 | 104,203 |
Basic Shares | 114,066 | 115,882 | 115,315 | 115,032 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $2,554,741 | $1,963,896 | $1,352,013 | $907,957 |
Gross Profit | 367,353 | 460,470 | 316,584 | 250,406 |
EBITDA | 84,854 | -24,785 | 43,746 | 55,661 |
EBIT | -38,314 | -148,200 | -46,505 | -4,376 |
Net Income | -61,623 | -113,040 | -19,164 | -37,601 |
Net Change In Cash | 2,554,741 | 1,963,896 | 1,352,013 | 907,957 |
Cost of Revenue | -139,127 | -6,587 | ||
Free Cash Flow | -6,128 | 113,837 | -49,914 | 13,764 |
Cash | 104,203 | 192,825 | 188,200 | 266,280 |
Basic Shares | 114,682 | 111,251 | 93,699 | 86,067 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | $0.05 |
2025-06-30 | -$0.10 |
2025-03-31 | $0.06 |
